MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The Association Between Inhibitory Control and Freezing of Gait Severity in Parkinson’s Disease

    E. Bayram, S. Banks, J. Longhurst, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate the relationship between inhibitory control and freezing of gait (FOG) severity in Parkinson’s disease (PD). Background: Inhibition deficits play a role in…
  • 2018 International Congress

    Affective Theory of Mind Impaired in Parkinson’s Disease: Negative- and Neutral- specific impairments of Emotion State Decoding

    C.H. Tan, S.C. Tu, R.L. Yu (Kaohsiung, Taiwan)

    Objective: The primary aim of this study was to investigate whether the ability to interpret positive, negative, or neutral emotion from a pair of photographed…
  • 2018 International Congress

    Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

    K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)

    Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
  • 2018 International Congress

    Predictive factors of fast cognitive decline in Parkinson’s disease after subthalamic stimulation: Myth or reality?

    F. Fluchere, F. Ory-Magne, M. Anheim, V. Rousseau, A. Eusebio, O. Lagha Boukbiza, B. Lemesle, T. Witjas, N. Longato, C. Tranchant, C. Brefel-Courbon, JP. Azulay (Marseille, France)

    Objective: To identify pre-operative factors of fast cognitive decline after subthalamic nucleus stimulation (STN DBS) in Parkinson’s disease (PD). Background: Cognitive outcome after STN DBS…
  • 2018 International Congress

    Resting-state fMRI in Parkinson’s disease patients with cognitive impairment: A meta-analysis

    A. Wolters, S. vd Weijer, A. Leentjens, A. Duits, H. Jacobs, M. Kuijf (Maastricht, Netherlands)

    Objective: To evaluate the patterns and magnitude of functional connectivity in resting-state brain networks in patients with Parkinson’s disease and cognitive impairment by pooling data…
  • 2018 International Congress

    Selection of antiparkinson drug and cognition in Japanese Parkinson Disease patients

    K. Konaka, Y. Kajiyama, R. Gajanan, M. Mihara, N. Hattori, H. Mochizuki (Suita, Japan)

    Objective: We attempted to analyze the correlation between dementia and internal medicine furthermore by elucidating the relevance to the frequently administered combination of antiparkinson drug.…
  • 2018 International Congress

    An analysis of cortical thickness in early Parkinson’s disease patients with cognitive impairment

    M. Mei, K. Nie, Y. Gao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To explore a possible relation between the changes of cortical thickness and cognitive deficits in patients with Parkinson’s disease (PD). Background: Cognitive impariment usually…
  • 2018 International Congress

    Plasma levels of vitamin D in patients with Parkinson’s disease: Correlation with Mini Mental State Examination and disease duration

    M. Barichella, L. Lorio, C. Bolliri, A. Giana, V. Ferri, G. Pinelli, E. Cassani, S. Caronni, C. Esposito, G. Riboldazzi, A. Maras, A. Perretti, F. Del Sorbo, P. Amadeo, R. Cilia, E. Cereda, G. Pezzoli (Milan, Italy)

    Objective: The aim of the study is to evaluate the plasma levels of 25(OH) D in PD, correlating these values with the cognitive function and…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

    A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)

    Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…
  • « Previous Page
  • 1
  • …
  • 1315
  • 1316
  • 1317
  • 1318
  • 1319
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley